| Dr Kathleen Anne Hogan, MD | |
|
17 Riverside St, Suite 101, Nashua, NH 03062-1304 | |
| (603) 883-0091 | |
| Not Available |
| Full Name | Dr Kathleen Anne Hogan |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 17 Riverside St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316028970 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Portsmouth, NH | Home health agency |
| Interim Healthcare | Manchester, NH | Home health agency |
| St Joseph Hospital | Nashua, NH | Hospital |
| Elliot Hospital | Manchester, NH | Hospital |
| Catholic Medical Center | Manchester, NH | Hospital |
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Four Seasons Orthopaedic Center Pllc | 5193791804 | 41 |
News Archive
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
The North American Menopause Society (NAMS) is pleased to announce the recipients of the Society's 2013 awards. The awards are given in recognition of exceptional contributions to menopause research, practice, and education; community service; and media.
Adults 50 and older are significantly less active than those younger than 50. Many fall short of the recommended 150 minutes of moderate to vigorous-intensity physical activity per week.
› Verified 4 days ago
| Entity Name | Four Seasons Orthopaedic Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881772242 PECOS PAC ID: 5193791804 Enrollment ID: O20040903000533 |
News Archive
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
The North American Menopause Society (NAMS) is pleased to announce the recipients of the Society's 2013 awards. The awards are given in recognition of exceptional contributions to menopause research, practice, and education; community service; and media.
Adults 50 and older are significantly less active than those younger than 50. Many fall short of the recommended 150 minutes of moderate to vigorous-intensity physical activity per week.
› Verified 4 days ago
| Entity Name | Northeast Orthopaedic Alliance Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417724170 PECOS PAC ID: 5991149809 Enrollment ID: O20240223001001 |
News Archive
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
The North American Menopause Society (NAMS) is pleased to announce the recipients of the Society's 2013 awards. The awards are given in recognition of exceptional contributions to menopause research, practice, and education; community service; and media.
Adults 50 and older are significantly less active than those younger than 50. Many fall short of the recommended 150 minutes of moderate to vigorous-intensity physical activity per week.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathleen Anne Hogan, MD 17 Riverside St, Suite 101, Nashua, NH 03062-1304 Ph: (603) 883-0091 | Dr Kathleen Anne Hogan, MD 17 Riverside St, Suite 101, Nashua, NH 03062-1304 Ph: (603) 883-0091 |
News Archive
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
The North American Menopause Society (NAMS) is pleased to announce the recipients of the Society's 2013 awards. The awards are given in recognition of exceptional contributions to menopause research, practice, and education; community service; and media.
Adults 50 and older are significantly less active than those younger than 50. Many fall short of the recommended 150 minutes of moderate to vigorous-intensity physical activity per week.
› Verified 4 days ago
Anand Padmanabha, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St Ste N203, Nashua, NH 03060 Phone: 603-577-2663 Fax: 603-577-3366 | |
Christian Matthew Klare, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St Ste 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
Daniel P Bouvier, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St, Suite 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
David P Richards, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 172 Kinsley St, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Dr. Albert Tom, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 168 Kinsley St, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Bryan Bean, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St Ste 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
Dr. Jason Benjamin Smoak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4000 |